An uncertified class action lawsuit filed in Calgary accuses major LPs of selling products whose THC and CBD contents are “drastically different” than are listed on containers. Among the defendants are LPs (or related entities) Aurora, Aleafia, Hexo, Cronos, Tilray, Organigram, and Medipharm.
Cannabis Law Report, Global News, Twitter–@MattPMaurer
- Plaintiff Lisa Marie Langevin bought a Tilray oil product but felt no effect on multiple uses. Lab analysis revealed the oil contained only 46% of the THC listed on the bottle. A second sample from the same lot contained 79% of the listed THC. (More details here.)
- Samples by several producers were tested by an independent lab: six had THC levels dramatically different than the amounts listed on the package. Two were much stronger, as much as 119% the listed THC content. Others were weaker. These allegations have not been proven.
Defendants have yet to respond, but will likely argue the product contents were accurate at the time of packaging.